News

Imaging Endpoints announced today that it has supported another U.S. Food and Drug Administration (FDA) approval for a new, life-saving therapy. The New Drug Application (NDA) was granted accelerated approval, for the Company’s pharmaceutical client, and is indicated for relapsed…   Read More

Imaging Endpoints is a leader in science and technology, providing comprehensive imaging services and technology solutions throughout the clinical trial process. Our 100-plus radiologists and physician specialists take a cutting-edge approach to clinical trials at every stage. Learn more about…   Read More

Imaging Endpoints has experienced more than a decade of high growth and is perhaps the fastest-growing imaging CRO globally. That is a testament to our amazing staff and their dedication to Connect Imaging to the Cure. Learn more about opportunities…   Read More

Imaging Endpoints is involved in cutting-edge COVID-19 imaging and offers the detection and standardized recording of the clinical and radiological disease features of COVID-19 infection, Radiomic Analysis, CD8+ Analysis and AI Analysis of SARS-CoV-2 for clinical trials. For more information,…   Read More

Did you miss the inaugural On Point webinar discussing how the use of radiology and advanced technologies can be used to measure response for COVID-19 treatments and vaccines and lead to better decisions? Visit https://imagingendpoints.com/on-point/ for an on-demand version of…   Read More